SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

Imago BioSciences Reports 'Positive' Data From Mid-Stage Trials of Bomedemstat in Bone Marrow Diseases

MT Newswires · 06/10/2022 01:06

Please log in to view news